Global Dialysis - ViroPharma Drops After Marrow Transplant Drug Flops in Study

ViroPharma Drops After Marrow Transplant Drug Flops in Study - Bloomberg

9 (Bloomberg) -- ViroPharma Inc. lost more than half its value in Nasdaq trading after its experimental drug for bone marrow transplant patients failed in ...